Evidence map›Paper›PMID 41624269›Full record

ArticleComputational and structural biotechnology journal2026

Bisdemethoxycurcumin attenuates myocardial fibrosis in heart failure with preserved ejection fraction by targeting TGFBR1 and oxidative stress.

Rong Xu, Guihua Cao, Liming Hou, Wei Fu, Chenting Bi, Xu Li, Xiaoming Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rong XuDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Guihua CaoDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Liming HouDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Wei FuDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Chenting BiDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Xu LiDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.
Xiaoming WangDepartment of Geriatrics, Xijing Hospital, The Airforce Military Medical University, Xi'an, Shaanxi 710032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bisdemethoxycurcumin (BDMC), a natural derivative of curcumin with improved solubility and stability, has shown potential cardioprotective properties. This study investigated the efficacy and underlying mechanisms of BDMC in heart failure with preserved ejection fraction (HFpEF) using both

Indexed as

BisdemethoxycurcuminExperimental validationHeart failure with preserved ejection fractionMolecular dockingNetwork pharmacology

Identifiers

PMID41624269
PMCPMC12855596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.